Beyaz

Drospirenone,

Ethinyl Estradiol,

Levomefolate Calcium

5.2 Moderate risk

Beyaz & Pulmonary embolism

33.8%

of users reported Pulmonary embolism

63.6%

also reported Hospitalization

100.0%

are women

Most common medical consequences

Hospitalization

63.6%

Severe reaction

22.7%

Life-threatening condition

9.1%

Death

4.5%

Have you experienced any negative side effects from this medication?

Beyaz: general information

Most common side effects (4)

Most commonly affected ages

20 - 29 years

45.5%

30 - 39 years

54.5%